Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)

India flag India · Delayed Price · Currency is INR
31.08
-1.33 (-4.10%)
At close: Jan 20, 2026
-44.39%
Market Cap485.77M
Revenue (ttm)455.49M
Net Income (ttm)28.59M
Shares Out16.27M
EPS (ttm)1.75
PE Ratio17.10
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume42,843
Average Volume15,473
Open33.00
Previous Close32.41
Day's Range30.00 - 33.00
52-Week Range30.30 - 58.99
Beta0.13
RSI32.04
Earnings DateFeb 11, 2026

About BOM:524396

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Phar... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 26
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524396
Full Company Profile

Financial Performance

In 2024, BOM:524396's revenue was 335.82 million, a decrease of -16.89% compared to the previous year's 404.09 million. Earnings were 5.58 million, a decrease of -21.36%.

Financial Statements